View Clinical Trial (Medical Research Study)
A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility Study - NCT01168284-21205(Clinical Trial 712377)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Baltimore |
|
State:
|
|
MD |
| Zip Code: |
|
21205 |
| Conditions: |
|
Autism Spectrum Disorders |
| Purpose: |
|
In recent years, there have been a growing number of individuals diagnosed with Autism
Spectrum Disorders (ASD). As such, this increase has expanded the number of caregivers of
children with ASD. Research has shown that having a child with an ASD is stressful for
caregivers and their families. More specifically, prior research suggests that caregivers of
children with ASD may find it difficult to maintain feelings of control and to cope with the
overall physical and emotional demands of caring for their child. A previous study of
caregivers of children with ASD found that caregivers felt a lack of personal control over
aspects of their child's condition and also found it difficult to cope with various demands
of caregiving. Furthermore, this study found that greater levels of perceived personal
control and the use of problem-focused coping strategies were associated with caregivers'
adaptation to their child's condition. As such, the goal of our research is to conduct a
feasibility study using a coping effectiveness training (CET) intervention designed to
enhance perceived personal control (PPC) and coping efficacy in caregivers of children with
ASD. There has been a growing interest in developing interventions targeted at constructs
involved in the adaptation process. However, there have been few studies of interventions
targeting predictors of adaptation such as PPC and coping efficacy. Research has shown that
the CET intervention can enhance coping efficacy in several other populations. This
intervention also incorporates appraisals of one's ability to change a particular situation.
The conceptual framework for our study was adapted from Lazarus and Folkman's Transactional
Model of Stress and Coping. A cross-sectional randomized treatment-control design is
proposed to evaluate the use of a CET intervention intended to enhance PPC and coping
efficacy. Caregivers of children with ASD will be recruited from support groups, autism
resource centers, and four clinics. Participants randomized to the treatment group will be
asked to complete baseline and follow-up surveys and two 1.5-hour individualized in-person
sessions. Participants randomized to the control group will be asked to complete baseline
and follow-up surveys and two 1.5-hour individualized in-person client-centered discussion
sessions. The main outcome measures will be participation, reasons for withdrawal,
participants' experiences within the intervention setting and their experiences in applying
the intervention, PPC, coping efficacy, and coping effectiveness.
|
| Study summary: |
|
In recent years, there have been a growing number of individuals diagnosed with Autism
Spectrum Disorders (ASD). As such, this increase has expanded the number of caregivers of
children with ASD. Research has shown that having a child with an ASD is stressful for
caregivers and their families. More specifically, prior research suggests that caregivers of
children with ASD may find it difficult to maintain feelings of control and to cope with the
overall physical and emotional demands of caring for their child. A previous study of
caregivers of children with ASD found that caregivers felt a lack of personal control over
aspects of their child's condition and also found it difficult to cope with various demands
of caregiving. Furthermore, this study found that greater levels of perceived personal
control and the use of problem-focused coping strategies were associated with caregivers'
adaptation to their child's condition. As such, the goal of our research is to conduct a
feasibility study using a coping effectiveness training (CET) intervention designed to
enhance perceived personal control (PPC) and coping efficacy in caregivers of children with
ASD. There has been a growing interest in developing interventions targeted at constructs
involved in the adaptation process. However, there have been few studies of interventions
targeting predictors of adaptation such as PPC and coping efficacy. Research has shown that
the CET intervention can enhance coping efficacy in several other populations. This
intervention also incorporates appraisals of one's ability to change a particular situation.
The conceptual framework for our study was adapted from Lazarus and Folkman's Transactional
Model of Stress and Coping. A cross-sectional randomized treatment-control design is
proposed to evaluate the use of a CET intervention intended to enhance PPC and coping
efficacy. Caregivers of children with ASD will be recruited from support groups, autism
resource centers, and four clinics. Participants randomized to the treatment group will be
asked to complete baseline and follow-up surveys and two 1.5-hour individualized in-person
sessions. Participants randomized to the control group will be asked to complete baseline
and follow-up surveys and two 1.5-hour individualized in-person client-centered discussion
sessions. The main outcome measures will be participation, reasons for withdrawal,
participants' experiences within the intervention setting and their experiences in applying
the intervention, PPC, coping efficacy, and coping effectiveness. |
| Criteria: |
|
- INCLUSION CRITERIA:
- Must be a primary caregiver (biological or adoptive parent or grandparent) of a child
with an ASD [note: no restrictions with regard to age of the child or how recently
s/he was diagnosed
- Must be at least 18 years of age
- Caregivers must reside with the child
- Only one caregiver per household and this person should be the caregiver that spends
the most time with the child.
- Must be able to read, write, and speak English
EXCLUSION CRITERIA:
- Those who have a child with any specific genetic diagnosis associated with ASD
[including Rett, Tuberous Sclerosis Complex, Fragile X Syndrome, Neurofibromatosis,
Prader-Willi Syndrome, and Angelman Syndrome will not be eligible to participate in this
study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
October 8, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|